Rubius Therapeutics was unable to secure financing to carry out its pivot to a new manufacturing process for its red blood cell-based cell therapies. The once high-flying biotech is now exploring options that could include a sale of the business or a merger with another company.
Health IT startup ZappRx has raised $1 million as part of a pivot from its e-prescribing platform to focus on automating the cumbersome manual process of ordering specialty pharmaceuticals. ZappRx wants to shorten to a few days a process that can take up to 10 days and accounts for a disproportionate amount of pharmaceutical costs, according […]
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.